Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
US9623127B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 8, 2011 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | Jun 23, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/2982
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.